Veritable’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-26,651
| Closed | -$12.5M | – | 464 |
|
|
2023
Q2 | $12.5M | Buy |
26,651
+400
| +2% | +$168K | 0.19% | 60 |
|
|
2023
Q1 | $9.02M | Sell |
26,251
-61
| -0.2% | -$20.6K | 0.15% | 74 |
|
|
2022
Q4 | $9.63M | Buy |
26,312
+172
| +0.7% | +$61K | 0.16% | 71 |
|
|
2022
Q3 | $8.45M | Buy |
26,140
+48
| +0.2% | +$15.2K | 0.16% | 73 |
|
|
2022
Q2 | $8.46M | Buy |
26,092
+1,064
| +4% | +$319K | 0.15% | 79 |
|
|
2022
Q1 | $7.17M | Sell |
25,028
-152
| -0.6% | -$39.1K | 0.11% | 101 |
|
|
2021
Q4 | $6.96M | Buy |
25,180
+62
| +0.2% | +$15.7K | 0.1% | 106 |
|
|
2021
Q3 | $5.8M | Buy |
25,118
+194
| +0.8% | +$47.9K | 0.09% | 115 |
|
|
2021
Q2 | $5.72M | Sell |
24,924
-56
| -0.2% | -$11.2K | 0.09% | 117 |
|
|
2021
Q1 | $4.67M | Sell |
24,980
-34
| -0.1% | -$6.65K | 0.08% | 128 |
|
|
2020
Q4 | $4.22M | Sell |
25,014
-2,983
| -11% | -$445K | 0.08% | 129 |
|
|
2020
Q3 | $4.14M | Buy |
27,997
+264
| +1% | +$40.9K | 0.08% | 123 |
|
|
2020
Q2 | $4.55M | Sell |
27,733
-2,877
| -9% | -$442K | 0.1% | 105 |
|
|
2020
Q1 | $4.25M | Sell |
30,610
-940
| -3% | -$129K | 0.1% | 106 |
|
|
2019
Q4 | $4.15M | Sell |
31,550
-216
| -0.7% | -$25K | 0.08% | 143 |
|
|
2019
Q3 | $3.55M | Buy |
31,766
+574
| +2% | +$63.9K | 0.07% | 148 |
|
|
2019
Q2 | $3.46M | Sell |
31,192
-252
| -0.8% | -$29.7K | 0.07% | 152 |
|
|
2019
Q1 | $4.08M | Buy |
31,444
+859
| +3% | +$104K | 0.08% | 136 |
|
|
2018
Q4 | $3.54M | Sell |
30,585
-368
| -1% | -$41.1K | 0.08% | 139 |
|
|
2018
Q3 | $3.32M | Buy |
30,953
+1,002
| +3% | +$100K | 0.07% | 156 |
|
|
2018
Q2 | $2.56M | Buy |
29,951
+1,026
| +4% | +$84.3K | 0.05% | 175 |
|
|
2018
Q1 | $2.24M | Buy |
28,925
+204
| +0.7% | +$16.4K | 0.05% | 192 |
|
|
2017
Q4 | $2.43M | Sell |
28,721
-24,161
| -46% | -$2.06M | 0.05% | 187 |
|
|
2017
Q3 | $4.52M | Buy |
52,882
+243
| +0.5% | +$19.9K | 0.1% | 126 |
|
|
2017
Q2 | $4.33M | Buy |
52,639
+1,560
| +3% | +$127K | 0.1% | 127 |
|
|
2017
Q1 | $4.3M | Buy |
51,079
+1,053
| +2% | +$84.3K | 0.1% | 118 |
|
|
2016
Q4 | $3.68M | Sell |
50,026
-2,643
| -5% | -$197K | 0.09% | 131 |
|
|
2016
Q3 | $4.23M | Buy |
52,669
+2,586
| +5% | +$207K | 0.11% | 120 |
|
|
2016
Q2 | $3.94M | Buy |
50,083
+3,807
| +8% | +$287K | 0.1% | 121 |
|
|
2016
Q1 | $3.33M | Sell |
46,276
-3,729
| -7% | -$282K | 0.09% | 133 |
|
|
2015
Q4 | $4.21M | Buy |
50,005
+1,863
| +4% | +$155K | 0.12% | 122 |
|
|
2015
Q3 | $4.03M | Buy |
48,142
+3,021
| +7% | +$255K | 0.12% | 121 |
|
|
2015
Q2 | $3.77M | Sell |
45,121
-8,730
| -16% | -$665K | 0.1% | 132 |
|
|
2015
Q1 | $3.91M | Buy |
53,851
+1,142
| +2% | +$81.3K | 0.08% | 171 |
|
|
2014
Q4 | $3.64M | Sell |
52,709
-385
| -0.7% | -$26K | 0.08% | 177 |
|
|
2014
Q3 | $3.44M | Sell |
53,094
-323
| -0.6% | -$20.4K | 0.07% | 181 |
|
|
2014
Q2 | $3.32M | Buy |
53,417
+98
| +0.2% | +$5.85K | 0.07% | 186 |
|
|
2014
Q1 | $3.14M | Sell |
53,319
-3,926
| -7% | -$219K | 0.07% | 190 |
|
|
2013
Q4 | $2.92M | Sell |
57,245
-2,059
| -3% | -$103K | 0.06% | 194 |
|
|
2013
Q3 | $2.98M | Buy |
59,304
+2,641
| +5% | +$138K | 0.07% | 185 |
|
|
2013
Q2 | $2.78M | Buy |
+56,663
| New | +$3.08M | 0.07% | 192 |
|
Other funds holding LLY
Veritable's LLY Position: Q3 2023 in Review
Veritable sold out of Eli Lilly (LLY) in Q3 2023, closing a stake of 26,651 shares — an estimated $12.5M sold.
Veritable first reported a position in LLY in Q2 2013 and held it in 41 quarters. The position peaked at $12.5M in Q2 2023. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.
- Veritable reported no remaining Eli Lilly position as of Q3 2023 after selling out during the quarter.
- Veritable sold 26,651 Eli Lilly shares in Q3 2023, an estimated $12.5M.
- Veritable first reported a position in Eli Lilly in Q2 2013 and held it in 41 quarters.
- Veritable's Eli Lilly position peaked at $12.5M in Q2 2023.
- 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.
Based on Veritable's 13F filing for Q3 2023.